CELESTIA: Cost-Effectiveness Analysis of Empagliflozin Versus Sitagliptin in Patients with Type 2 Diabetes in Greece

Ghetti G, Pradelli L, Papageorgiou G, Karpouzos G, Arikan Y

ClinicoEconomics and Outcomes Research 2023, 15:97-109

Published Date: 17 February 2023